Search

everythinglearnresearchcommunity

for

Search:↓

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Tinea capitis can cause scalp issues in children and should be considered in similar cases; treatment with griseofulvin and selenium sulfide is effective.

Minoxidil can cause deadly skin reaction; monitor patients closely.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

A man's chest hair turned white after a shingles infection, possibly due to virus-damaged pigment cells.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Herbal preparation effectively promotes hair growth and reduces hair loss.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Finasteride causes reduced tear flow and severe eye inflammation.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

New hair transplant method allows for hair regrowth in the donor area and less scarring.

Viral warts are common in children, so prevention against HPV is important.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.